Stockscreener 앱 받기
4.40
2.65%
-0.12
Vivos Therapeutics Inc 주식(VVOS)의 최신 뉴스
Applying Elliott Wave Theory to Vivos Therapeutics Inc.Chart Risk Profile for Capital Preservation - Newser
Is Vivos Therapeutics Inc. meeting your algorithmic filter criteriaFree Profit Target Stock Opportunity Monitor - Newser
Vivos Therapeutics (NASDAQ:VVOS) Lowered to “Sell” Rating by Wall Street Zen - Defense World
Vivos Therapeutics Inc. stock trend forecastAlpha Trade Flow With Risk Calibration - Newser
What data driven models say about Vivos Therapeutics Inc.’s futureWeekly Trend Screener with Momentum Picks - Newser
Quantitative breakdown of Vivos Therapeutics Inc. recent movePrice Movement and Market Sentiment Analysis - Newser
What makes Vivos Therapeutics Inc. stock price move sharplyBuy and Hold Position Summary Review - Newser
Visual trend scoring systems applied to Vivos Therapeutics Inc.Stock Entry Point Planner with Volume Spike - Newser
Detecting price anomalies in Vivos Therapeutics Inc. with AIFree Stock Portfolio Allocation Guidance - Newser
Vivos Therapeutics Inc expected to post a loss of 38 cents a shareEarnings Preview - TradingView
Can momentum traders help lift Vivos Therapeutics Inc.Short-Term Swing Opportunity Summary Sheet - Newser
Understanding Vivos Therapeutics Inc.’s price movementFree Buy Low Sell High Stock Watch - Newser
Published on: 2025-08-09 06:46:19 - Newser
Is Vivos Therapeutics Inc. stock poised for growthRisk-Managed Trade Alerts for Consistency - Newser
Vivos Calls Out Medical Blind Spot: OSA's Overlooked Dangerous Symptoms - Yahoo Finance
How Interest Rate Changes Impact Vivos Therapeutics Inc. Stock PerformanceAI Risk Optimized Trade Forecast Planner - Newser
Should you hold or exit Vivos Therapeutics Inc. nowLong-Term Growth Trend Summary With Confidence - Newser
Vivos Therapeutics (NASDAQ:VVOS) Upgraded at Wall Street Zen - Defense World
Relief Rally in Vivos Therapeutics Inc. Stock — Can It HoldEntry Plan for Oversold Reversal Stocks Released - metal.it
Can you recover from losses in Vivos Therapeutics Inc.Trend Reversal Watch with Entry Signals - Newser
How does Vivos Therapeutics Inc. compare to its industry peersExceptional profit margins - Jammu Links News
What is the dividend policy of Vivos Therapeutics Inc. stockConsistent triple returns - Jammu Links News
Vivos Therapeutics Inc. Stock Analysis and ForecastRapid wealth multiplication - Jammu Links News
What are the latest earnings results for Vivos Therapeutics Inc.Discover stocks with massive upside potential - Jammu Links News
What catalysts could drive Vivos Therapeutics Inc. stock higher in 2025Capitalize on market trends with confidence - Jammu Links News
Is Vivos Therapeutics Inc. stock overvalued or undervaluedAchieve breakthrough financial results today - Jammu Links News
What is the risk reward ratio of investing in Vivos Therapeutics Inc. stockDiscover breakthrough investment opportunities - Jammu Links News
Why is Vivos Therapeutics Inc. stock attracting strong analyst attentionUnlock expert market analysis instantly - Jammu Links News
Should I hold or sell Vivos Therapeutics Inc. stock in 2025Capitalize on trading strategies that deliver - Jammu Links News
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Short Interest Update - Defense World
How volatile is Vivos Therapeutics Inc. stock compared to the marketMaximize gains with expert trading strategies - Jammu Links News
Is Vivos Therapeutics Inc. a growth stock or a value stockBuild a portfolio for long-term financial success - Jammu Links News
Is Vivos Therapeutics Inc. reversing from oversold territoryShort-Term Support and Resistance Forecast - Newser
Vivos Therapeutics Skyrockets 21.7%—Can This Momentum Sustain the Bull Run? - AInvest
Short interest data insights for Vivos Therapeutics Inc.Capital Growth Plan for New Investors - Newser
Vivos Therapeutics, Inc.'s (NASDAQ:VVOS) Shares Climb 43% But Its Business Is Yet to Catch Up - 富途牛牛
Opera Limited shares rise 1.56% premarket after recent executive appointments at Vivos Therapeutics, Inc. - AInvest
1.17%
자본화:
|
볼륨(24시간):